WEHI’s research into blood cancer spans from investigating the molecules that drive blood cancers through to drug development and testing, and involvement in clinical trials.
We particularly focus on:
WEHI’s blood cancer research spans more than 60 years and has underpinned the development of new medicines that have improved treatment for millions of patients.
Cancers arise through genetic changes in cells that make them divide and grow uncontrollably.
Blood cancers arise from changes in cells of the blood system, often either developing blood cells or immune (white blood) cells. They cause illness by depriving other cells of the space and nutrients they need to function properly.
Our researchers are not able to provide specific medical advice specific to individuals. If you have cancer and wish to find out more information about clinical trials, please visit the Australian Cancer Trials or the Australian New Zealand Clinical Trials Registry, or consult your medical specialist.
The following organisations provide support for people with specific cancer types and their carers: